Prudential Financial Inc. raised its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,927 shares of the health services provider's stock after buying an additional 3,669 shares during the quarter. Prudential Financial Inc.'s holdings in Maximus were worth $1,637,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares during the period. Bridge City Capital LLC grew its holdings in shares of Maximus by 0.9% during the fourth quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock worth $2,128,000 after purchasing an additional 254 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Maximus during the fourth quarter valued at $1,821,000. AXQ Capital LP acquired a new position in shares of Maximus during the fourth quarter valued at $206,000. Finally, Hillsdale Investment Management Inc. lifted its stake in Maximus by 0.4% in the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock valued at $3,912,000 after buying an additional 230 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several equities analysts have weighed in on MMS shares. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.
Check Out Our Latest Research Report on MMS
Maximus Price Performance
Shares of MMS traded down $0.59 during midday trading on Thursday, hitting $67.29. The company's stock had a trading volume of 55,446 shares, compared to its average volume of 543,205. The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of 14.47 and a beta of 0.68. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The company's fifty day simple moving average is $68.20 and its two-hundred day simple moving average is $76.49.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio is presently 25.81%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.